-
Behind the $5 billion deal, Akeso has three endings
In the era of China's innovative drug exploration, the record of BD going to sea has been constantly refreshed.
2022-12-12 15:27 -
Ranked 9th! Guorui Biotech ranks among the forefront of China's CDMO enterprises in 2022
As a national high-tech enterprise, Guorui Biotech deserves to win the award!
2022-12-12 15:27 -
Tencent Tang Daosheng: Accelerate the embrace of digital health and activate the endogenous power of...
Tencent Tang Daosheng!
2022-12-05 15:30 -
Lilly gave up the overseas rights and interests of Cindilimab, and Cinda PD-1 had difficulty going t...
What else is possible?
2022-12-05 15:30 -
Treatment Guide' for Alopecia Starman
The world suffers from hair loss for a long time.
2022-12-05 15:30 -
The NASH market is in full swing! At a glance of the latest R&D progress, who will 'reach the top'?
A list of 6 pharmaceutical companies.
2022-12-05 15:30 -
Who fired the first shot of high-end equipment independent controllability?
Today, dig into domestic leaders in various subdivisions, how to be the first to break the import monopoly.
2022-12-02 17:47 -
Next month, 'IVF' medical insurance reimbursement landed! Hundreds of billions of markets support th...
The "test tube baby" track with high industry barriers and low penetration rate is ready to go.
2022-12-02 17:45 -
Ascletis announces that 180 patients have been enrolled in the Phase II clinical trial of ASC40 for ...
Up to now, about 50% of the enrolled patients have completed 12 weeks of treatment.
2022-12-02 17:42 -
How far behind is the vaccine industry?
The anti-epidemic situation is grim, and domestic vaccines still need to be worked on.
2022-12-01 11:16
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products